AstraZeneca gets nod to launch cancer drug – Times of India
NEW DELHI: AstraZeneca Pharma India has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs…
AstraZeneca aims for $80 billion in sales by 2030 – Times of India
AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot seeks to cement his legacy at the British drugmaker that he helped…
1 in 3 Covaxin recipients hit by adverse events: Study | India News – Times of India
NEW DELHI/HYDERABAD: Nearly one-third of those who took Covaxin jabs suffered 'adverse events of special interest' within a year of getting vaccinated, claims a study in Drug Safety, an academic…